tiprankstipranks
Genomma Lab Internacional SAB de CV Class B (GNMLF)
OTHER OTC:GNMLF
US Market
GNMLF
Genomma Lab Internacional SAB de CV
RESEARCH TOOLSreports

Genomma Lab Internacional SAB de CV (GNMLF) Financial Statements

16 Followers

Genomma Lab Internacional SAB de CV Financial Overview

Genomma Lab Internacional SAB de CV's market cap is currently $842.88M. The company's EPS TTM is $0.6; its P/E ratio is 8.59; and it has a dividend yield of 4.48%. Genomma Lab Internacional SAB de CV is scheduled to report earnings on April 23, 2026, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 17.54B$ 18.61B$ 16.47B$ 16.82B$ 15.49B
Gross Profit$ 11.02B$ 11.93B$ 10.08B$ 10.16B$ 9.56B
Operating Income$ 3.76B$ 3.92B$ 3.26B$ 3.25B$ 3.05B
EBITDA$ 3.61B$ 4.14B$ 2.78B$ 3.01B$ 2.84B
Net Income$ 1.61B$ 1.49B$ 1.08B$ 1.39B$ 1.31B
Balance Sheet
Cash & Short-Term Investments$ 3.05B$ 2.37B$ 1.66B$ 1.50B$ 1.22B
Total Assets$ 23.83B$ 23.02B$ 20.74B$ 21.61B$ 21.54B
Total Debt$ 7.63B$ 6.49B$ 6.24B$ 6.44B$ 5.96B
Net Debt$ 4.79B$ 4.21B$ 4.77B$ 4.94B$ 4.74B
Total Liabilities$ 12.72B$ 12.13B$ 11.30B$ 11.45B$ 11.47B
Stockholders' Equity$ 11.11B$ 10.88B$ 9.44B$ 10.15B$ 10.07B
Cash Flow
Free Cash Flow$ 2.03B$ 2.36B$ 2.16B$ 2.04B$ 1.26B
Operating Cash Flow$ 2.05B$ 3.03B$ 2.25B$ 2.05B$ 1.47B
Investing Cash Flow$ -752.80M$ -731.97M$ -302.21M$ -282.30M$ -765.62M
Financing Cash Flow$ -475.40M$ -1.59B$ -1.68B$ -1.36B$ -1.47B
Currency in MXN

Genomma Lab Internacional SAB de CV Earnings and Revenue History

Income Statement >

Genomma Lab Internacional SAB de CV Debt to Assets

Balance Sheet >

Genomma Lab Internacional SAB de CV Cash Flow

Cash Flow >

Genomma Lab Internacional SAB de CV Forecast EPS vs Actual EPS

Earnings >